| abstract |
FIELD: medicine. n SUBSTANCE: invention relates to medicine, namely to clinical immunology and allergology. Method includes the preliminary preparation of autologous lymphocytes from the patient's venous blood. After this, they are activated with anti-CD3 antibodies and recombinant human interleukin-2. Then cultivate for at least 10 days. Subcutaneous administration of activated lymphocytes is initiated by the initiation course once a week for 4 weeks. Subsequent maintenance course of treatment is carried out for 6 months, carrying out one injection per month. At same time, one dose contains from 30 million to 60 million autologous activated T-lymphocytes in two milliliters of saline. Treatment is carried out simultaneously with the basic therapy with inhalants. n EFFECT: method for treating bronchial asthma is provided. n 1 cl, 4 tbl, 3 ex, 1 dwg |